# Amgen Inc: Form 8-K, filed Sep 12, 2023

- Company: [Amgen Inc](/companies/amgn.md) (CIK 318154)
- Form: 8-K
- Filed: 2023-09-12
- Accepted by EDGAR: Sep 12, 2023, 07:30 ET
- Period: 2023-09-11
- Accession: 0001193125-23-233011
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/318154/000119312523233011/d523167d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/318154/000119312523233011/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/318154/000119312523233011/d523167d8k.htm

Filed Sep 12, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-233011. Last ingested by Listed: Nov 10, 2026, 06:19 ET. No prices; not investment advice.
